Handgrip strength evaluation in CKD: do we have enough evidence?

被引：0
|
作者：
Leal, Viviane O. [1 ]
Mafra, Denise [2 ]
机构：
[1] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil
[2] Univ Fed Fluminense, Niteroi, RJ, Brazil
来源：
JORNAL BRASILEIRO DE NEFROLOGIA | 2020年 / 42卷 / 04期
关键词：
D O I：
10.1590/2175-8239-JBN-2020-0209
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：388 / 390
页数：3
相关论文
共 50 条
  • [41] What Do We Do When We Don't Have Enough Time?
    Schirmer, Eleni
    NATION, 2024, 319 (03)
  • [42] Do Direct Oral Anticoagulants Have Cardiovascular Benefits in CKD? We Need More Evidence
    Shin, Jung-Im
    Grams, Morgan E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (03) : 306 - 307
  • [43] Do we have enough evidence to recommend hydroxyapatite toothpaste for preventing dental caries?Caries
    Neeraj Gugnani
    Shalini Gugnani
    Evidence-Based Dentistry, 2025, 26 (1) : 38 - 39
  • [44] The forgotten sixth sense in cerebral palsy: do we have enough evidence for proprioceptive treatment?
    Yardimci-Lokmanoglu, Bilge Nur
    Bingol, Hasan
    Mutlu, Akmer
    DISABILITY AND REHABILITATION, 2020, 42 (25) : 3581 - 3590
  • [45] Platelet Function Testing Before CABG is Recommended in the Guidelines: But Do We Have Enough Evidence?
    Mahla, Elisabeth
    Tantry, Udaya S.
    Gurbel, Paul A.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2015, 28 (03) : 233 - 235
  • [46] Flow capacity, how much is enough, do we have it, do we need more?
    Auth, D
    JOURNAL OF INVASIVE CARDIOLOGY, 1997, 9 (02): : 162 - 163
  • [47] HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: DO WE HAVE ENOUGH THERAPY?
    Andrade, M. M.
    Fonseca, I.
    Freire, S.
    Cruz, D.
    ATHEROSCLEROSIS, 2023, 379 : S112 - S112
  • [48] The optimal treatment of zygomycosis: Do we have enough data?
    Petrikkos, G. L.
    MYCOSES, 2012, 55 : 53 - 53
  • [49] Past, present and future - Do we have enough of U?
    Macdonald, C
    NUCLEAR ENGINEERING INTERNATIONAL, 2004, 49 (594): : 38 - 39
  • [50] Statins and dilated cardiomyopathy: do we have enough data?
    Bielecka-Dabrowa, Agata
    Mikhailidis, Dimitri P.
    Hannam, Simon
    Aronow, Wilbert S.
    Rysz, Jacek
    Banach, Maciej
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (03) : 315 - 323
12345